Applied Imaging gets FDA OK for HER2 testing
This article was originally published in Clinica
Executive Summary
The US FDA has given Applied Imaging the green light to sell an automated microscopy-based test that can help identify women who are likely to respond to the drug, Herceptin (trastuzumab).